Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

1.20
+0.130012.15%
Post-market: 1.200.00000.00%19:56 EDT
Volume:383.45K
Turnover:432.51K
Market Cap:72.69M
PE:-0.62
High:1.21
Open:1.09
Low:1.06
Close:1.07
Loading ...
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Correspondence

Form CORRESP - Correspondence
Mar 27, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report